Objective : To improve cytological evaluation of therapeutic effects induced by radiation therapy (RT) and concurrent chemoradiotherapy (CCRT) in uterine cervical squamous cell carcinoma (UCSCC), we reevaluated routine cytological diagnosis.
Study Design : Cytological specimens numbering 207 from 53 UCSCC subjects-13 undergoing RT and 40 CCRT-were divided into positive, negative, and indeterminate categories and reevaluated together with Ki-67 expression and human papilloma virus (HPV) infection status. Histological reevaluation was also done with a magnetic resonance imaging (MRI) study.
Results : Positive cytological reevaluation ratios declined linearly-30 Gy at 69%, 40 Gy at 44%, 50 Gy at 30%, 60 Gy at 13%-somewhat differing from routine diagnosis. The Ki-67 index was consistent with reevaluation-30% positive, 0.6% negative, and 6% indeterminate. HPV infection persisted in positive specimens, and 73% of cytological reevaluation agreed with imaging study diagnosis.
Conclusions : Cytological examination quality in determining RT and CCRT effects is improved by comprehensively evaluating clinical-information-based cytological specimens. Three-tiered positive, negative, and indeterminate evaluation is recommended instead of Papanicolaou classification.
View full abstract